Latent heart failure (NYHA class: II-III), ischemic heart disease (CCS class: II-III), peripheral artery disease (Fontaine class: II-IV), pulmonary artery hypertension (WHO class: II-III)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Latent CHF NYHA class: II-III CTR<70% on chest X-P LVEF>30% on echo-cardiogram Ischemic heart disease Old myocardial infarction or stable angina with treated by adequate revascularization before 30 days Peripheral artery disease Arteriosclerosis obliterans or Buerger's disease with treated by adequate revascularization before 30 days Fontaine class: II-IV Pulmonary artery hypertension WHO class: II-III Mean pulmonary artery pressure<50 mmHg No deep vein thrombus and acute pulmonary artery thrombus * It is necessary that any subjects have already received enough treatment before the entry.
Exclusion criteria
Exclusion criteria: Hard to fit the training device Skin, muscle, or bone disease in limbs Implantation of cardiac pacemaker Uncontrolled hypertension Blood pressure at rest>160/100 mmHg Uncontrolled arrhythmia Arrhythmia with unstable hemodynamics Pregnancy Malignant diseases on no-remission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation 24 weeks after the training. Safety: injuries of skin and/or muscle by electrical stimulation during the training. Efficacy: symptoms, metabolic disorder (DM, dyslipidemia, etc.), cardiac function, vascular function, and hemodynamics. | — |
Countries
Japan
Contacts
Kurume University The Cardiovascular Research Institute